Global Pharmaceuticals & Biotech Top Stock Picks from Analysts

Daiichi Sankyo Company

Market Cap: JP¥5.2t

Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.

Insmed

Market Cap: US$30.1b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

Sino Biopharmaceutical

Market Cap: HK$106.4b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

Akeso

Market Cap: HK$101.5b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

Summit Therapeutics

Market Cap: US$12.5b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

BioMarin Pharmaceutical

Market Cap: US$11.3b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Madrigal Pharmaceuticals

Market Cap: US$10.2b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

Tempus AI

Market Cap: US$8.9b

Operates as a healthcare technology company in the United States.

WuXi XDC Cayman

Market Cap: HK$68.1b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

ImmunityBio

Market Cap: US$8.6b

A biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient’s immune system and deliver durable protection against cancer and infectious diseases.

Praxis Precision Medicines

Market Cap: US$8.2b

A clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance in the United States.

Vaxcyte

Market Cap: US$7.9b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Haisco Pharmaceutical Group

Market Cap: CN¥51.4b

Researches, develops, manufactures, and sells pharmaceutical products primarily in China.

Cytokinetics

Market Cap: US$7.4b

A biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States.

3SBio

Market Cap: HK$52.1b

An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.

Grifols

Market Cap: €5.7b

Engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally.

Kymera Therapeutics

Market Cap: US$6.5b

A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.

Repligen

Market Cap: US$6.4b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

CSPC Innovation Pharmaceutical

Market Cap: CN¥41.8b

Engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally.

Rhythm Pharmaceuticals

Market Cap: US$6.0b

A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United States and internationally.

Caliway Biopharmaceuticals

Market Cap: NT$187.9b

Engages in the development of drugs for aesthetic medicine and chronic inflammation.

Chongqing Zhifei Biological Products

Market Cap: CN¥38.7b

Chongqing Zhifei Biological Products Co., Ltd.

Cogent Biosciences

Market Cap: US$5.5b

A clinical-stage biotechnology company, focuses on developing precision therapies for genetically defined diseases.

Changchun High-Tech Industry (Group)

Market Cap: CN¥36.3b

Researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China.

Caris Life Sciences

Market Cap: US$5.1b

An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.

Immunovant

Market Cap: US$5.0b

A clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases.

CRISPR Therapeutics

Market Cap: US$4.7b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

Shanghai Henlius Biotech

Market Cap: HK$36.3b

Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.

Alkermes

Market Cap: US$4.6b

A biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.

TG Therapeutics

Market Cap: US$4.1b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Dianthus Therapeutics

Market Cap: US$4.1b

A clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases.

Viking Therapeutics

Market Cap: US$4.1b

A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.

Shanghai Junshi Biosciences

Market Cap: HK$32.2b

A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China.

Stevanato Group

Market Cap: US$4.1b

Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

Crinetics Pharmaceuticals

Market Cap: US$3.9b

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Indivior Pharmaceuticals

Market Cap: US$3.9b

Engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.